Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug;46(4):722-730.
doi: 10.1111/ijlh.14283. Epub 2024 Apr 29.

Improving platelet function following prophylactic platelet transfusion in patients with hematological malignancies

Yi-Feng Wu  1   2   3 , Chih-Lung Shen  1 , Wei-Han Huang  1   4 , Sung-Chao Chu  1   2 , Chi-Cheng Li  1   5 , Chao-Zong Liu  6 , Tso-Fu Wang  1   2
Affiliations

Improving platelet function following prophylactic platelet transfusion in patients with hematological malignancies

Yi-Feng Wu et al. Int J Lab Hematol. 2024 Aug.

Erratum in

Abstract

Introduction: Platelet transfusion is a standard treatment to prevent bleeding in patients with hematological malignancies. Although transfusions can improve platelet count, their impact on platelet function remains controversial.

Methods: We conducted flow cytometry to assess platelet function before and after transfusion and performed subgroup analyses to examine differences based on blood type, corrected count increment (CCI), and platelet microparticles.

Results: Overall, 50 patients who received prophylactic platelet transfusion were enrolled. CD42b expression increased, whereas CD41 expression decreased after transfusion. Apheresis platelets exhibited the lowest expression of PAC-1 and P-selectin when exposed to agonist stimulations. PAC-1 expression increased under high adenosine diphosphate (ADP) stimulation, while P-selectin expression increased under both high ADP and thrombin receptor-activating peptide stimulation. In the subgroup analysis, patients with a CCI >4500 and those with the same blood types exhibited a more significant increase in PAC-1 and P-selectin expression under agonist stimulation. When comparing apheresis platelets collected on different days, only the percentage of platelet-derived microparticles showed a significant increase.

Conclusion: Prophylactic transfusion improved platelet function. Platelet function significantly improved in patients with a CCI >4500, those with the same blood types as that of apheresis platelets, or those with platelet-derived microparticle levels <4.7%. No significant improvement in platelet function was noted after the transfusion of different blood types with acceptable compatibility or the transfusion of incompatible blood types. Our results suggest that transfusing platelets with the same blood type remains the optimal choice.

Keywords: apheresis; flow cytometry; platelet; thrombocytopenia; transfusion.

PubMed Disclaimer

References

REFERENCES

    1. Slichter SJ. Relationship between platelet count and bleeding risk in thrombocytopenic patients. Transfus Med Rev. 2004;18:153‐167.
    1. Stanworth SJ, Estcourt LJ, Llewelyn CA, Murphy MF, Wood EM, TOPPS Study Investigators. Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial. Transfusion. 2014;54:2385‐2393.
    1. Stanworth SJ, Estcourt LJ, Powter G, et al. A no‐prophylaxis platelet‐transfusion strategy for hematologic cancers. N Engl J Med. 2013;368:1771‐1780.
    1. van Baarle FLF, van de Weerdt EK, van der Velden WJFM, et al. Platelet transfusion before CVC placement in patients with thrombocytopenia. N Engl J Med. 2023;388:1956‐1965.
    1. He Y, Liang S, Xu Y, Wan C, Ma F, Wang B. The analysis of the effect of blood transfusion on changes of blood platelet parameters in patients with leukemia treated with chemotherapy. Evid Based Complement Alternat Med. 2022;2022:2901993.

LinkOut - more resources